Sangamo Therapeutics Inc (NASDAQ:SGMO)

16.13
Delayed Data
As of Jun 21
 -1.93 / -10.66%
Today’s Change
7.35
Today|||52-Week Range
27.50
-1.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues8.3M11.8M13.1M12.6M
 
 
 
 
 
Depreciation And Amortization317.0K412.0K468.0K588.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses20.7M24.4M26.4M33.0M
 
 
 
 
 
Research And Development15.0M18.4M19.4M23.5M
 
 
 
 
 
Total Operating Expenses21.0M24.8M26.8M33.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.8M-13.0M-13.8M-21.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.5M-12.4M-13.1M-20.2M
 
 
 
 
 
Net Income-12.5M-12.4M-13.1M-20.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS72.5M83.8M84.8M86.3M
 
 
 
 
 
Shares To Calculate EPS Diluted72.5M83.8M84.8M86.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.17-$0.15-$0.15-$0.23
 
 
 
 
 
EPS Diluted-$0.17-$0.15-$0.15-$0.23